| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in BRVE over the last quarter tilts toward buying: insiders added a net 7,480,000 shares worth roughly $134.6M. In the past 30 days, 3 insiders bought and 0 sold. The tilt toward buying has held up recently.
The largest recent buyer is Chimovits Erez (Director, 10% Owner), now holding an estimated $214.2M in BRVE.
Classified under Biotechnology (Healthcare sector), BRVE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 11.90M | $315.76M | +1.94M | |
| 10% | 10.24M | $271.54M | +1.94M | |
| 10% | 9.72M | $257.89M | +3.60M | |
| 10% | 7.42M | $196.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% Owner | Buy | 3,600,000 | $18.00 | $64,800,000.00 | +19.8% | |
| Aug 7, 2026 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 1,940,000 | $18.00 | $34,920,000.00 | +19.0% | |
| Aug 7, 2026 | Chimovits Erez | Director, 10% Owner | Buy | 1,940,000 | $18.00 | $34,920,000.00 | +19.0% |